Fusix Biotech GmbH

Fusix Biotech GmbH is a pioneering biotechnology research company specializing in innovative solutions for cancer immunotherapy. As a spin-out from the Technical University of Munich, Fusix Biotech GmbH is dedicated to the clinical and commercial development of a proprietary oncolytic virus platform, setting new standards in the field. Fusix Biotech GmbH operates with a focus on cutting-edge research and development, striving to bring advanced therapeutic options to patients in need.

Located in München, DE, Fusix Biotech GmbH is committed to advancing the science of oncolytic viruses and their application in cancer treatment. With a dedicated team of experts, Fusix Biotech GmbH leverages its unique platform to create novel immunotherapies that harness the power of the body's own immune system to fight cancer. The company's commitment to innovation and excellence positions it as a key player in the biotechnology sector.

Fusix Biotech GmbH is poised for continued growth and success, driven by its commitment to improving patient outcomes through groundbreaking research. We invite the management team at Fusix Biotech GmbH to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, where you can further highlight your expertise and contributions to the biotechnology field.